Remote Health
Recent news:
MEng alumna Alison Burklund, the cofounder and CTO of Nanopath, has been named to the Forbes 30 Under 30 list. Nanopath creates diagnostics that test pelvic and gynecologic infections during a single visit, so treatment can begin right away.
Check out this Medgadget interview with BioE alumna Charvi Shetty, founder and CEO of Aluna, which makes an FDA-approved at-home spirometer for asthma management.
Patrick Hsu’s lab has developed an RNA-extraction-free test for rapid viral detection using saliva via a microfluidic device. The fast, accurate, and portable prototype shows potential as a point-of-care system to support frequent, on-site molecular diagnostics. This work was the August 2022 cover story for Nature Biomedical Engineering.
Professor Iain Clark, in partnership with graduate program faculty member Adam Abate, was able to analyze single cells harboring latent HIV using a technique that isolates single, infected cells as tiny amounts of blood move through their microfluidic devices. Their work was featured in Science news.
Developed by former BioE postdoc Kiana Aran, the CRISPR-Chip now in use in Cardea Bio’s CRISPR-SNP-Chip has been named one of 2021’s Top 10 Innovations by The Scientist magazine. The new chip is the first device capable of detecting single base differences in DNA without generating millions of copies of the DNA first.
Patrick Hsu, Liana Lareau and Daniel Fletcher have collaborated on a new rapid COVID test that rivals the sensitivity of the gold-standard qRT-PCR testing, with results in less than an hour.
Congratulations to BioE PhD alumna Kate Rosenbluth, founder of Cala Health, named to Forbes’ list of “52 Women-Led Startups Driving The Future Of HealthTech And FemTech”. Cala Health creates non-invasive wearable neuromodulation therapies for patients living with chronic diseases.
The FDA has authorized the first single-use, PCR-quality, over the counter COVID-19 test kit, made by alumni startup Lucira!
The San Francisco Business Times examines crucial work by Dan Fletcher, Melanie Ott and Jennifer Doudna to create an efficient, smartphone-based CRISPR-cellscope hybrid COVID-19 test.
- « Previous
- 1
- 2
- 3
- Next »